Log in to save to my catalogue

Increased Glypican-3 immunostaining is associated with longer survival outcomes in colorectal carcin...

Increased Glypican-3 immunostaining is associated with longer survival outcomes in colorectal carcin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cbfd6d79c24b4e6f80eea3efc4db5c63

Increased Glypican-3 immunostaining is associated with longer survival outcomes in colorectal carcinoma

About this item

Full title

Increased Glypican-3 immunostaining is associated with longer survival outcomes in colorectal carcinoma

Publisher

Warsaw: Termedia Publishing House

Journal title

Polish journal of pathology, 2022-01, Vol.73 (1), p.14-20

Language

English

Formats

Publication information

Publisher

Warsaw: Termedia Publishing House

More information

Scope and Contents

Contents

Glypicans (GPC) are involved in the developmental morphogenesis and regulatory processes of cell signalling. Abnormal expression has been observed in different cancer types. One hundred and thirty-seven colorectal carcinoma (CRC) and 44 nodal metastases were used to create tissue microarrays. Immunohistochemistry was done to detect and evaluate the...

Alternative Titles

Full title

Increased Glypican-3 immunostaining is associated with longer survival outcomes in colorectal carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_cbfd6d79c24b4e6f80eea3efc4db5c63

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cbfd6d79c24b4e6f80eea3efc4db5c63

Other Identifiers

ISSN

1233-9687

E-ISSN

2084-9869

DOI

10.5114/pjp.2022.117172

How to access this item